Title Created Date
1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells 05 July 2017
1,25-Dihydroxyvitamin D3 and its analogues inhibit acute myelogenous leukemia progenitor proliferation by suppressing interleukin-1beta production 04 July 2017
Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3 27 June 2017
1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1 21 June 2017
1 alpha,25-dihydroxyvitamin D3 plus gamma-interferon blocks lung tumor production of granulocyte-macrophage colony-stimulating factor and induction of immunosuppressor cells 21 June 2017
Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors 16 June 2017
A cross-linking assay allows the detection of receptors for the somatostatin analogue, lanreotide in human breast tumours 15 June 2017
Analysis of somatostatin receptor subtype mRNA expression in human breast cancer 31 May 2017
A phase II study of high-dose octreotide in patients with unresectable pancreatic carcinoma 30 May 2017
1,25-Dihydroxyvitamin D3 potentiates the cytotoxic effect of TNF on human breast cancer cells 30 May 2017
Display #